FFCP PHASE1:Mm9::chr5:98460318..98460329,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr5:98460318..98460329,+|id=chr5:98460318..98460329,+|ontology_enrichment_celltype=CL:0000838!2.46e-13!12;CL:0000542!3.00e-12!13;CL:0000051!3.00e-12!13;CL:0000988!2.69e-11!32;CL:0002032!2.69e-11!32;CL:0000037!2.69e-11!32;CL:0000566!2.69e-11!32;CL:0000837!2.69e-11!32;CL:0000084!7.15e-11!11;CL:0000827!7.15e-11!11;CL:0000624!1.34e-10!8;CL:0000791!2.12e-09!9;CL:0000789!2.12e-09!9;CL:0002420!2.12e-09!9;CL:0002419!2.12e-09!9;CL:0000790!2.12e-09!9;CL:0000893!2.88e-09!6;CL:0002489!2.88e-09!6;CL:0000898!2.88e-09!6;CL:0000809!2.88e-09!6;CL:0000810!2.88e-09!6;CL:0000895!2.88e-09!6;CL:0000808!2.88e-09!6;CL:0000894!2.88e-09!6;CL:0000806!2.88e-09!6;CL:0000807!2.88e-09!6;CL:0000805!2.88e-09!6;CL:0002425!2.88e-09!6;CL:0002436!2.88e-09!6;CL:0002427!2.88e-09!6;CL:0002428!2.88e-09!6;CL:0002429!2.88e-09!6;CL:0002433!2.88e-09!6;CL:0002431!2.88e-09!6;CL:0002432!2.88e-09!6;CL:0000738!3.55e-09!17;CL:0002087!3.55e-09!17;CL:0002031!8.08e-08!25;CL:0000034!1.80e-07!97;CL:0002320!2.77e-07!46;CL:0000134!2.77e-07!46;CL:0000144!3.82e-07!121;CL:0000012!3.82e-07!121;CL:0000219!4.13e-07!54|ontology_enrichment_celltype_v019_2=CL:0000355,4.60e-15,9|ontology_enrichment_disease=DOID:0060100!2.49e-12!3;DOID:4045!2.49e-12!3|ontology_enrichment_disease_v019_2=DOID:0060100,2.45e-43,3;DOID:4045,2.45e-43,3;DOID:0050686,3.68e-22,6|ontology_enrichment_uberon=UBERON:0002384!2.77e-07!46|ontology_enrichment_uberon_v019_2=UBERON:0001134,4.60e-15,9;UBERON:0002036,4.60e-15,9;UBERON:0002385,4.60e-15,9;UBERON:0000486,4.60e-15,9;UBERON:0007503,4.60e-15,9;UBERON:0001015,4.60e-15,9;UBERON:0002329,4.60e-15,9;UBERON:0003082,4.60e-15,9;UBERON:0003059,4.60e-15,9;UBERON:0007282,4.60e-15,9;UBERON:0004290,4.60e-15,9;UBERON:0009618,4.60e-15,9;UBERON:0000383,1.22e-13,10;UBERON:0007524,1.80e-12,11;UBERON:0003077,1.80e-12,11;UBERON:0007285,1.80e-12,11|phase1_expression=0,0,0,0,0,0,0,0.258246646883153,0.140788722151667,0.234064526321993,0,0,0.171200729931206,0.0874204024189974,0,0,0,0,0.274228867211478,0,0,0,0.261199789138935,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.53356935326434,6.2506827561904,5.23523743973798,31.1762688656438,12.9778642142105,11.1667381197165,0,0,0,0,0,0,0,0,0,0.167782606057736,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.075726193333184,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.505524445014783,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.239630249011841,0,0.127070227073065,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.284163499395593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.167506257441816,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.32977250588296,0,0,0,0,0,0,0.170870880797853,0,0,0,0,0,0,0.979660166265606,0.276399947608848,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0897138566094757,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr5:98460318..98460329,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr5:98460318..98460329,+ | |||
|description=CAGE_peak_at_chr5:98460318..98460329,+ | |||
|id=chr5:98460318..98460329,+ | |||
|ontology_enrichment_celltype=CL:0000838!2.46e-13!12;CL:0000542!3.00e-12!13;CL:0000051!3.00e-12!13;CL:0000988!2.69e-11!32;CL:0002032!2.69e-11!32;CL:0000037!2.69e-11!32;CL:0000566!2.69e-11!32;CL:0000837!2.69e-11!32;CL:0000084!7.15e-11!11;CL:0000827!7.15e-11!11;CL:0000624!1.34e-10!8;CL:0000791!2.12e-09!9;CL:0000789!2.12e-09!9;CL:0002420!2.12e-09!9;CL:0002419!2.12e-09!9;CL:0000790!2.12e-09!9;CL:0000893!2.88e-09!6;CL:0002489!2.88e-09!6;CL:0000898!2.88e-09!6;CL:0000809!2.88e-09!6;CL:0000810!2.88e-09!6;CL:0000895!2.88e-09!6;CL:0000808!2.88e-09!6;CL:0000894!2.88e-09!6;CL:0000806!2.88e-09!6;CL:0000807!2.88e-09!6;CL:0000805!2.88e-09!6;CL:0002425!2.88e-09!6;CL:0002436!2.88e-09!6;CL:0002427!2.88e-09!6;CL:0002428!2.88e-09!6;CL:0002429!2.88e-09!6;CL:0002433!2.88e-09!6;CL:0002431!2.88e-09!6;CL:0002432!2.88e-09!6;CL:0000738!3.55e-09!17;CL:0002087!3.55e-09!17;CL:0002031!8.08e-08!25;CL:0000034!1.80e-07!97;CL:0002320!2.77e-07!46;CL:0000134!2.77e-07!46;CL:0000144!3.82e-07!121;CL:0000012!3.82e-07!121;CL:0000219!4.13e-07!54 | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,4.60e-15,9 | |||
|ontology_enrichment_disease=DOID:0060100!2.49e-12!3;DOID:4045!2.49e-12!3 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,2.45e-43,3;DOID:4045,2.45e-43,3;DOID:0050686,3.68e-22,6 | |||
|ontology_enrichment_uberon=UBERON:0002384!2.77e-07!46 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,4.60e-15,9;UBERON:0002036,4.60e-15,9;UBERON:0002385,4.60e-15,9;UBERON:0000486,4.60e-15,9;UBERON:0007503,4.60e-15,9;UBERON:0001015,4.60e-15,9;UBERON:0002329,4.60e-15,9;UBERON:0003082,4.60e-15,9;UBERON:0003059,4.60e-15,9;UBERON:0007282,4.60e-15,9;UBERON:0004290,4.60e-15,9;UBERON:0009618,4.60e-15,9;UBERON:0000383,1.22e-13,10;UBERON:0007524,1.80e-12,11;UBERON:0003077,1.80e-12,11;UBERON:0007285,1.80e-12,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0.258246646883153,0.140788722151667,0.234064526321993,0,0,0.171200729931206,0.0874204024189974,0,0,0,0,0.274228867211478,0,0,0,0.261199789138935,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.53356935326434,6.2506827561904,5.23523743973798,31.1762688656438,12.9778642142105,11.1667381197165,0,0,0,0,0,0,0,0,0,0.167782606057736,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.075726193333184,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.505524445014783,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.239630249011841,0,0.127070227073065,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.284163499395593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.167506257441816,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.32977250588296,0,0,0,0,0,0,0.170870880797853,0,0,0,0,0,0,0.979660166265606,0.276399947608848,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0897138566094757,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr5:98460318..98460329,+ | |||
}} |
Latest revision as of 20:23, 4 August 2015
Short description: | p@chr5:98460318..98460329, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr5:98460318..98460329, + |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 4.60e-15 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 4.60e-15 | 9 |
striated muscle tissue | 4.60e-15 | 9 |
muscle tissue | 4.60e-15 | 9 |
multilaminar epithelium | 4.60e-15 | 9 |
epithelial vesicle | 4.60e-15 | 9 |
musculature | 4.60e-15 | 9 |
somite | 4.60e-15 | 9 |
myotome | 4.60e-15 | 9 |
presomitic mesoderm | 4.60e-15 | 9 |
presumptive segmental plate | 4.60e-15 | 9 |
dermomyotome | 4.60e-15 | 9 |
trunk paraxial mesoderm | 4.60e-15 | 9 |
musculature of body | 1.22e-13 | 10 |
dense mesenchyme tissue | 1.80e-12 | 11 |
paraxial mesoderm | 1.80e-12 | 11 |
presumptive paraxial mesoderm | 1.80e-12 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 2.45e-43 | 3 |
muscle cancer | 2.45e-43 | 3 |
organ system cancer | 3.68e-22 | 6 |